RedHill Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.97	4.62	5.57	19.97	29.47
Short-Term Investments	-	-	-	0.02	8.53
Cash & Short-Term Investments	3.97	4.62	5.57	19.98	38
Cash Growth	-13.99%	-17.09%	-72.13%	-47.42%	27.56%
Accounts Receivable	0.08	2.54	2.59	34.52	31.68
Inventory	-	3.65	4.39	11.01	14.81
Other Current Assets	2.48	1.1	3.59	20.39	4.66
Total Current Assets	6.53	11.91	16.14	85.9	89.15
Net Property, Plant & Equipment	1.11	0.44	1.18	7.19	4.22
Other Intangible Assets	5.29	5.55	5.58	65.63	71.64
Long-Term Investments	12.05	-	-	-	-
Other Long-Term Assets	0.37	0.15	0.15	0.15	16.17
Total Assets	25.35	18.04	23.05	158.87	181.19
Accounts Payable	0.73	1.17	3.28	4.23	11.66
Accrued Expenses	12.02	9.99	4.59	17.95	20.9
Current Portion of Long-Term Debt	-	-	-	115.22	-
Current Portion of Leases	0.17	0.35	0.72	1.03	1.62
Other Current Liabilities	6.3	10.71	11.4	59.03	47.29
Total Current Liabilities	19.22	22.22	19.98	197.45	81.47
Long-Term Debt	-	-	-	-	83.62
Long-Term Leases	0.9	0	0.46	6.44	2.57
Other Long-Term Liabilities	0.96	0.5	0.54	3.37	4.65
Total Long-Term Liabilities	1.86	0.5	1	9.82	90.84
Total Liabilities	21.08	22.73	20.98	207.27	172.31
Common Stock	147.64	35.04	21.44	2.84	1.5
Additional Paid-in Capital	270.38	375.08	388.36	382.63	375.25
Retained Earnings	-413.76	-414.8	-407.74	-433.86	-367.87
Shareholders' Equity	4.27	-4.68	2.07	-48.4	8.88
Total Liabilities & Equity	25.35	18.04	23.05	158.87	181.19
Total Debt	1.07	0.36	1.17	122.69	87.81
Net Cash (Debt)	2.9	4.26	4.4	-102.71	-49.81
Net Cash Growth	-31.92%	-3.07%	-	-	-
Net Cash Per Share	0.92	3.46	16.96	-1666.53	-1070.51
Book Value	4.27	-4.68	2.07	-48.4	8.88
Book Value Per Share	1.35	-3.80	7.98	-785.33	190.75
Tangible Book Value	-1.02	-10.23	-3.51	-114.03	-62.77
Tangible Book Value Per Share	-0.32	-8.30	-13.54	-1850.17	-1349.08

SEC Filings: 10-K · 10-Q